98 related articles for article (PubMed ID: 8643207)
1. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.
Weidmann P; Schneider M; Böhlen L
Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():39-45. PubMed ID: 8643207
[No Abstract] [Full Text] [Related]
2. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment.
Parving HH; Andersen AR; Smidt U; Friisberg B; Bonnevie-Nielsen V; Svendsen PA
Acta Endocrinol Suppl (Copenh); 1981; 242():39-40. PubMed ID: 6940399
[No Abstract] [Full Text] [Related]
3. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
[TBL] [Abstract][Full Text] [Related]
4. [Decrease of microalbuminuria caused by antihypertensive treatment in 10 diabetics with incipient diabetic nephropathy].
Grimaldi A; Bosquet F; Coutarel P; Digy JP; Bordas M; Carayon A
Ann Med Interne (Paris); 1987; 138(7):556-7. PubMed ID: 3439678
[No Abstract] [Full Text] [Related]
5. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
[TBL] [Abstract][Full Text] [Related]
6. Effects of different antihypertensive drugs on human diabetic proteinuria.
Weidmann P; Boehlen LM; de Courten M
Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
[No Abstract] [Full Text] [Related]
7. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
Chantrel F; Bouiller M; Kolb I; Hannedouche T
Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
Tamsma JT; van der Woude FJ; Lemkes HH
Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
[TBL] [Abstract][Full Text] [Related]
11. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
van Nieuwkoop C; Ijpelaar DH; Bolk JH
Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
[TBL] [Abstract][Full Text] [Related]
12. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure reduction is necessary for the reduction of proteinuria in diabetic nephropathy--comparison of different antihypertensive agents.
Berger ED; Setzler BA; Werz U; Bader BD; Lipp HP; Risler T; Erley CM
Nephrol Dial Transplant; 1999; 14 Suppl 4():28-9. PubMed ID: 10463204
[No Abstract] [Full Text] [Related]
14. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
[TBL] [Abstract][Full Text] [Related]
15. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
16. Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
de Zeeuw D
Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105
[TBL] [Abstract][Full Text] [Related]
17. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
18. Early screening for nephropathy initiative.
Monsaert RP
Del Med J; 2006 Apr; 78(4):153-4. PubMed ID: 16719144
[No Abstract] [Full Text] [Related]
19. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
20. Impact of hypertension and antihypertensive treatment on kidney function in diabetic nephropathy.
Hommel EE
Dan Med Bull; 1994 Apr; 41(2):167-78. PubMed ID: 8039432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
